Overview

A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

Status:
Completed
Trial end date:
2019-11-19
Target enrollment:
Participant gender:
Summary
A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis
Phase:
Phase 2
Details
Lead Sponsor:
Aristea Therapeutics, Inc.
Treatments:
Pharmaceutical Solutions